Elisa Degenkolbe

A Drug Resistance Screen Using a Selective MET Inhibitor Reveals a Spectrum of Mutations That Partially Overlap with Activating Mutations Found in Cancer Patients

Ralph Tiedt, Elisa Degenkolbe, Pascal Furet et al. · Cancer Research · 2011 · 135 citations · Full text

Medicine, Oncology, Pharmacology +14

MiR-497∼195 Cluster MicroRNAs Regulate Osteoblast Differentiation by Targeting BMP Signaling

Johannes Grünhagen, Raghu Bhushan, Elisa Degenkolbe et al. · Journal of Bone and Mineral Research · 2014 · 62 citations · Full text

Life Sciences, Developmental Biology, Molecular Biology +17

A GDF5 Point Mutation Strikes Twice - Causing BDA1 and SYNS2

Elisa Degenkolbe, Jana König, Julia Zimmer et al. · PLoS Genetics · 2013 · 45 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Improved bone defect healing by a superagonistic GDF5 variant derived from a patient with multiple synostoses syndrome

Elisa Degenkolbe, Carolin Schwarz, Claus‐Eric Ott et al. · Bone · 2014 · 13 citations · Full text

Medicine, Orthopaedic Surgery, Surgery +15